Anges Québec, Fier Succès commit $1.2 mln in follow-on funding to Feldan
Members of Anges Québec, Anges Québec Capital Fund and Fier Succès have partnered to invest $1.225 million of follow-on funding in Feldan, a biopharmaceutical company based in Québec City. The round, the third in a series of financings by Anges Québec since 2011, was co-led by entrepreneurs Sylvain Chartier and Jean-Marc Rousseau. Established in 2007, Feldan is focused on supplying quality reagents necessary for the growth and differentiation of stem cells outside the human body. Last month, Anges Québec Capital Fund, a fund established to invest alongside Anges Québec members, was recapitalized at $85 million.
25 March 2015•4 mins read
